Spectral Medical (EDT) Competitors C$0.82 -0.01 (-1.20%) As of 08/1/2025 02:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and NBLYShould you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Neighbourly Pharmacy (NBLY). These companies are all part of the "medical" sector. Spectral Medical vs. Its Competitors Akumin GeneNews LED Medical Diagnostics LexaGene SQI Diagnostics 3D Signatures Med Biogene Biomark Diagnostics Charles River Laboratories International Neighbourly Pharmacy Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability. Which has more risk & volatility, EDT or AKU? Spectral Medical has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, meaning that its share price is 85% less volatile than the S&P 500. Is EDT or AKU more profitable? Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral MedicalN/A -973.97% -93.22% Akumin -34.67%-483.86%0.47% Does the media refer more to EDT or AKU? In the previous week, Spectral Medical's average media sentiment score of 0.00 equaled Akumin'saverage media sentiment score. Company Overall Sentiment Spectral Medical Neutral Akumin Neutral Which has stronger valuation and earnings, EDT or AKU? Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral MedicalC$1.90M121.38-C$18.68M-C$0.07-11.71AkuminC$737.69M0.00-C$255.80M-C$3.80N/A Do insiders & institutionals have more ownership in EDT or AKU? 13.0% of Spectral Medical shares are held by institutional investors. Comparatively, 30.3% of Akumin shares are held by institutional investors. 18.2% of Spectral Medical shares are held by insiders. Comparatively, 33.0% of Akumin shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryAkumin beats Spectral Medical on 6 of the 10 factors compared between the two stocks. Get Spectral Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDT vs. The Competition Export to ExcelMetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE ExchangeMarket CapC$230.63MC$847.16MC$5.47BC$6.20BDividend Yield1.45%5.44%4.74%6.72%P/E Ratio-11.712.1828.6763.43Price / Sales121.38483.56422.261,251.00Price / Cash82.5011.4235.4583.29Price / Book-10.252.708.274.87Net Income-C$18.68MC$334.07BC$3.24BC$301.20M7 Day Performance-1.20%-1.46%-3.63%-2.26%1 Month Performance1.23%-2.14%4.40%0.81%1 Year Performance38.98%-7.51%25.97%26.63% Spectral Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDTSpectral MedicalN/AC$0.82-1.2%N/A+41.4%C$230.63MC$1.90M-11.7129AKUAkuminN/AN/AN/AN/AC$37.20MC$737.69M-0.141,527GENGeneNewsN/AN/AN/AN/AC$25.49MC$234.59K-2.212,700LMDLED Medical DiagnosticsN/AC$0.40+∞N/A+0.0%C$15.51MC$14.96M-10.2646Gap UpLXGLexaGeneN/AC$0.11-19.2%N/A+0.0%C$14.77MC$110.93K-1.3141High Trading VolumeSQDSQI DiagnosticsN/AC$0.02flatN/A+0.0%C$6.11MC$3.04M-0.30147,000Gap UpDXD3D SignaturesN/AC$0.04+∞N/A+0.0%C$2.66MN/A-0.91N/AGap UpMBIMed BiogeneN/AC$0.05-18.2%N/A+0.0%C$597KN/A-7.5080Gap DownBUXBiomark DiagnosticsN/AN/AN/AN/A$0.00N/A0.00N/ANews CoveragePositive NewsGap DownHigh Trading VolumeCRLCharles River Laboratories InternationalN/AN/AN/AN/A$0.00N/A0.0021,400News CoverageGap DownNBLYNeighbourly PharmacyN/AN/AN/AN/AC$835.51MC$874.61M-25.483,648High Trading Volume Related Companies and Tools Related Companies Akumin Competitors GeneNews Competitors LED Medical Diagnostics Competitors LexaGene Competitors SQI Diagnostics Competitors 3D Signatures Competitors Med Biogene Competitors Biomark Diagnostics Competitors Charles River Laboratories International Competitors Neighbourly Pharmacy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:EDT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
